Senate Bipartisan Clinical Trials Registry Bill Includes Device Firms
This article was originally published in The Gray Sheet
Executive Summary
Medical device companies would be required to register clinical trials in a publicly accessible national databank as a condition of Institutional Review Board approval under a Senate bill introduced Feb. 28